Tacrolimus and Mycophenolate Mofetil as Second-Line Therapies for Pediatric Patients with Autoimmune Hepatitis

被引：0
|
作者：
Cumali Efe
Haider Al Taii
Henriette Ytting
Niklas Aehling
Rahima A. Bhanji
Hannes Hagström
Tugrul Purnak
Luigi Muratori
Mårten Werner
Paolo Muratori
Daniel Klintman
Thomas D. Schiano
Aldo J. Montano-Loza
Thomas Berg
Fin Stolze Larsen
Naim Alkhouri
Ersan Ozaslan
Michael A. Heneghan
Eric M. Yoshida
Staffan Wahlin
机构：
[1] Hacettepe University,Department of Gastroenterology
[2] Cleveland Clinic Foundation,Department of Medicine
[3] University of Copenhagen,Department of Hepatology, Rigshospitalet
[4] Universitätsklinikum Leipzig,Sektion Hepatologie, Klinik für Gastroenterologie und Rheumatologie
[5] University of Alberta,Division of Gastroenterology and Liver Unit
[6] Karolinska Institutet and Karolinska University Hospital,Hepatology Division, Centre for Digestive Diseases
[7] Alma Mater Studiorum – Università di Bologna,Centro per lo Studio e la Cura delle Malattie Autoimmuni del Fegato e delle Vie Biliari
[8] Umeå University,Dipartimento di Scienze Mediche e Chirurgiche (DIMEC)
[9] Skåne University Hospital,Department of Public Health and Clinical Medicine
[10] The Mount Sinai Medical Center,Department of Molecular and Clinical Medicine
[11] Texas Liver Institute,Division of Liver Diseases/Transplantation Institute
[12] Numune Research and Education Hospital,Department of Gastroenterology
[13] King’s College Hospital NHS Foundation Trust,Institute of Liver Studies
[14] University of British Columbia and Vancouver General Hospital,Division of Gastroenterology
来源：
Digestive Diseases and Sciences | 2018年 / 63卷
关键词：
Autoimmune hepatitis; Mycophenolate mofetil; Tacrolimus; Second-line; Cirrhosis; Pediatric; Liver transplantation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1348 / 1354
页数：6
相关论文
共 50 条
  • [1] Tacrolimus and Mycophenolate Mofetil as Second-Line Therapies for Pediatric Patients with Autoimmune Hepatitis
    Efe, Cumali
    Al Taii, Haider
    Ytting, Henriette
    Aehling, Niklas
    Bhanji, Rahima A.
    Hagstrom, Hannes
    Purnak, Tugrul
    Muratori, Luigi
    Werner, Marten
    Muratori, Paolo
    Klintman, Daniel
    Schiano, Thomas D.
    Montano-Loza, Aldo J.
    Berg, Thomas
    Larsen, Fin Stolze
    Alkhouri, Naim
    Ozaslan, Ersan
    Heneghan, Michael A.
    Yoshida, Eric M.
    Wahlin, Staffan
    [J]. DIGESTIVE DISEASES AND SCIENCES, 2018, 63 (05) : 1348 - 1354
  • [2] Efficacy and Safety of Mycophenolate Mofetil and Tacrolimus as Second-line Therapy for Patients With Autoimmune Hepatitis
    Efe, Cumali
    Hagstrom, Hannes
    Ytting, Henriette
    Bhanji, Rahima A.
    Muller, Niklas F.
    Wang, Qixia
    Purnak, Tugrul
    Muratori, Luigi
    Werner, Marten
    Marschall, Hanns-Ulrich
    Muratori, Paolo
    Gunsar, Fulya
    Klintman, Daniel
    Pares, Albert
    Heurgue-Berlot, Alexandra
    Schiano, Thomas D.
    Cengiz, Mustafa
    Tana, Michele May-Sien
    Ma, Xiong
    Montano-Loza, Aldo J.
    Berg, Thomas
    Verma, Sumita
    Larsen, Fin Stolze
    Ozaslan, Ersan
    Heneghan, Michael A.
    Yoshida, Eric M.
    Wahlin, Staffan
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2017, 15 (12) : 1950 - +
  • [3] Tacrolimus and mycophenolate mofetil as second-line treatment in autoimmune hepatitis:Is the evidence of sufficient quality to develop recommendations?
    Mohammadreza Abdollahi
    Neda Khalilian Ekrami
    Morteza Ghojazadeh
    H Marike Boezen
    Mohammadhossein Somi
    Behrooz Z Alizadeh
    [J]. World Journal of Gastroenterology, 2020, (38) : 5896 - 5910
  • [4] Tacrolimus and mycophenolate mofetil as second-line treatment in autoimmune hepatitis: Is the evidence of sufficient quality to develop recommendations?
    Abdollahi, Mohammadreza
    Ekrami, Neda Khalilian
    Ghojazadeh, Morteza
    Boezen, H. Marike
    Somi, Mohammadhossein
    Alizadeh, Behrooz Z.
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2020, 26 (38) : 5896 - 5910
  • [5] Second-Line Treatment of Autoimmune Hepatitis: Mycophenolate Mofetil as an effective Treatment Option?
    Ploch, P.
    Marquardt, J.
    Fritsche, S.
    Krupp, M.
    Galle, P.
    Teufel, A.
    Barreiros, A.
    [J]. INTERNIST, 2013, 54 : 26 - 26
  • [6] Mycophenolate Mofetil as Second Line Therapy in Autoimmune Hepatitis?
    Hennes, Elke M.
    Oo, Ye H.
    Schramm, Christoph
    Denzer, Ulrike
    Buggisch, Peter
    Wiegard, Christiane
    Kanzler, Stephan
    Schuchmann, Marcus
    Boecher, Wulf
    Galle, Peter R.
    Adams, David H.
    Lohse, Ansgar W.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2008, 103 (12): : 3063 - 3070
  • [7] MYCOPHENOLATE MOFETIL AS SECOND-LINE THERAPY FOR AUTOIMMUNE HEPATITIS: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Santiago, Priscila
    Tamariz, Leonardo
    Schwartz, Ingrid
    Levy, Cynthia
    [J]. GASTROENTEROLOGY, 2018, 154 (06) : S1098 - S1098
  • [8] Systematic review with meta-analysis: mycophenolate mofetil as a second-line therapy for autoimmune hepatitis
    Santiago, Priscila
    Schwartz, Ingrid
    Tamariz, Leonardo
    Levy, Cynthia
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2019, 49 (07) : 830 - 839
  • [9] Tacrolimus or Mycophenylate mofetil as a second-line therapeutic options in patients with Autoimmune Hepatitis: An international multicentre observational study
    Efe, Cumali
    Hagstrom, Hannes
    Bhanji, Rahima A.
    Mueller, Niklas F.
    Wang, Qixia
    Purnak, Tugrul
    Muratori, Luigi
    Werner, Marten
    Marschall, Hanns-Ulrich
    Muratori, Paolo
    Gunsar, Fulya
    Klintman, Daniel
    Pares, Albert
    Heurgue-Berlot, Alexandra
    Schiano, Thomas D.
    Ma, Xiong
    Montano-Loza, Aldo J.
    Berg, Thomas
    Ozaslan, Ersan
    Yoshida, Eric M.
    Wahlin, Staffan
    [J]. HEPATOLOGY, 2015, 62 : 368A - 368A
  • [10] Second Line Therapy in Autoimmune Hepatitis: is Mycophenolate Mofetil an effective option?
    Ploch, Philippe
    Marquardt, Jens U.
    Fritzsche, Susanne
    Krupp, Markus
    Galle, Peter R.
    Teufel, Andreas
    Barreiros, Ana P.
    [J]. HEPATOLOGY, 2012, 56 : 724A - 724A
12345